Enclosed herewith Board Meeting Intimation for Board Meeting dated 13/02/2026
Awaiting price reaction for this filing.
Nutricircle Ltd has informed BSE that its Board of Directors will meet on Friday, 13 February 2026 at 3:00 p.m. at the registered office in Hyderabad. The Board will consider and approve the un-audited standalone financial results for the quarter and nine months ended 31 December 2025, along with the Limited Review report. Additionally, the Board will consider the allotment and conversion of convertible warrants into equity shares of Rs. 10 each on a preferential basis to a Promoter and Director, based on a special resolution passed by shareholders on 24 September 2024 and BSE's in-principal approval dated 24 December 2024. This is an advance intimation under SEBI Listing Regulations 29(1) and 33, with no actual financial numbers disclosed yet.
Investors should watch for the Q3 FY26 results announcement on or after 13 February for actual revenue and profit numbers. The warrant conversion to the Promoter/Director will result in equity dilution for existing shareholders, though the shares are being issued at face value (Rs. 10) on a preferential basis as previously approved.